Efficacy of melphalan, arsenic trioxide, and ascorbic acid combination therapy (MAC) in relapsed and refractory multiple myeloma [10]

M. J. Borad, R. Swift, J. R. Berenson

Research output: Contribution to journal › Letter › peer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy of melphalan, arsenic trioxide, and ascorbic acid combination therapy (MAC) in relapsed and refractory multiple myeloma [10]'. Together they form a unique fingerprint.